HOLLAND, Mich., March 4th, 2019– Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its investment into Embody, Inc.
cultivate(MD) Announces Investment Into Embody, Inc. Read More »
HOLLAND, Mich., December 3rd, 2018— cultivate(MD) Seed Fund, a fund focused on investments in early-stage healthcare companies with innovative technologies, announces its investment into SpinTech.
cultivate(MD) Announces Investment Into SpinTech Read More »
HOLLAND, Mich., November 20th, 2018—Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments in early-stage healthcare companies with innovative technologies, announces its investment into Medical Ingenuities, LLC.
cultivate(MD) Announces Investment Into Medical Ingenuities, LLC. Read More »
HOLLAND, Mich., Nov. 5, 2018 /PRNewswire/ — Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System. This is a key addition to their expanding shoulder portfolio and another milestone for their vision to offer a complete leading technology shoulder arthroplasty product line.
Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology Read More »
HOLLAND, Mich., Oct. 22, 2018 Shoulder Innovations, an emerging leader in the development of shoulder replacement systems, announced today it has closed a $2.5 million round of Series A equity funding led by Ann Arbor-based Michigan Angel Fund, Grand Rapids-based Wakestream Ventures, ProVoyance, cultivate(MD)and other equity holders.
Shoulder Innovations Announces Close Of $2.5 Million Round In Series A Investment Read More »
HOLLAND, Mich., July 19, 2018— Genesis Innovation Group, LLC, announces the formation of HAPPE Spine LLC as well as investments by cultivate(MD) Capital Fund I, LLC and cultivate(MD) Seed Fund into HAPPE Spine.
cultivate(MD) Funds Announces Investment Into HAPPE Spine Read More »
HOLLAND, Mich., July 10, 2018—Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments in early-stage healthcare companies with innovative technologies, announces its investment into SafKan Health, Inc.
cultivate(MD) Announces Investment Into SafKan Health Read More »
Genesis Innovation Group and cultivate (MD) Capital Funds are dedicated to bringing emerging health care innovations to market. HOLLAND, Mich., March 6, 2018 —Genesis Innovation Group, LLC, (Genesis) an emerging developer of medical device technologies, today announced that cultivate(MD) Capital Fund GP, LLC (cultivate(MD)), has closed its first tranche of $7.2M in capital funds of
cultivate(MD) Capital Funds Announces First Tranche Closing Read More »
HOLLAND, Mich., December 2017 – Shoulder Innovations, an emerging developer of shoulder replacement systems, today announced it closed a $1.6 million round of Series A equity funding. Demand for the company’s innovative shoulder replacement technology continues to grow, driving Shoulder Innovations’ sales revenues more than 380% during 2017.
Shoulder Innovations Revenue Grows 380%, Closes $1.6 Million Round Series A Investment Read More »
$10 Million Fund is dedicated to bringing emerging healthcare innovations to market. HOLLAND, Mich., November 28, 2017— Genesis Innovation Group, LLC, an emerging developer of medical device technologies, today announced the formation of cultivate(MD) Capital Fund I, LLC, a venture capital fund focused on investing in early-stage healthcare companies, with special focus on medical device
Genesis Innovation Group Launches cultivate(MD) Capital Fund Read More »
